AVLNAvalyn Pharma Inc.

$26.02

Who owns AVLN

92 institutions reported holding AVLN for 2026Q2.

92

Institutions reporting a position · as of 2026Q2

Shares held by institutions
44.0M

Shares held by institutions · long US equity positions only, as reported on Form 13F

Reported value
$1.45B

Reported value · at Jun 30, 2026 prices, not today's

Opened vs closed
89 / 0

Opened vs closed · new positions against positions exited in the latest quarter

Details›
Reporting quarter2026-06-30
2026Q2
Quarters on record
1
New positions
89
Positions exited
0
Added to
0
Reduced
0
Shares sold shortsettled Sep 30, 2026
2.5M
Short interestof shares outstanding
5.7%
Days to coverat the average daily volume
8.5
Change in the short positionsince the Sep 15, 2026 count
+20%
Largest reported holders, 2026Q2
HolderShares% of companyValue
FMR LLC5.8Mn/a$192M
NOVO HOLDINGS A/S3.9Mn/a$128M
SR One Capital Management, LP3.3Mn/a$109M
PERCEPTIVE ADVISORS LLC2.7Mn/a$88M
MONTANOVA CAPITAL, LLC2.5Mn/a$82M
NVP ASSOCIATES, LLC2.3Mn/a$75M
WELLINGTON MANAGEMENT GROUP LLP2.2Mn/a$72M
PRICE T ROWE ASSOCIATES INC /MD/1.7Mn/a$57M
Catalio Capital Management, LP1.7Mn/a$55M
T. Rowe Price Investment Management, Inc.1.6Mn/a$53M
Short interest by settlement date, May 15, 2026 to Sep 30, 2026
SettlementShares shortOf shares outstandingDays to cover
Sep 30, 20262.5M5.7%8.5
Sep 15, 20262.1M4.7%9.6
Aug 31, 20261.9M4.4%11.3
Aug 14, 20262.1M4.7%10.9
Jul 31, 20262.0M4.6%9.4
Jul 15, 20262.2M4.9%5.6
Jun 30, 20262.2M4.9%3.1
Jun 15, 20261.3M3.0%5.5
May 29, 20260.9M2.0%3.2
May 15, 20260.6M1.3%1.4

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold. The short position is FINRA's consolidated count for each twice-monthly settlement date, as a share of shares outstanding.

opening the register…
On our screens:Stocks with no debt